Management of large Trigeminal Schwannoma: long-term oncologic and functional outcome from a multicentric retrospective cohort

Choucha, Anis; Troude, Lucas; Morin, Laura; Fernandes, Sarah; Baucher, Guillaume; De Simone, Matteo; Lihi, Abir; Mazen, Kallel; Alseirihi, Motaz; Passeri, Thibault; Gay, Emmanuel; Fournier, Henri-Dominique; Jacquesson, Timothée; Jouanneau, Emmanuel; Froelich, Sebastien; Roche, Pierre-Hugues

doi:10.1007/s00701-024-06292-8

Acta Neurochir

2024

DOI: 10.1007/s00701-024-06292-8

|View full text |Cite

Management of large Trigeminal Schwannoma: long-term oncologic and functional outcome from a multicentric retrospective cohort

Anis Choucha,

Lucas Troude,

Laura Morin

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology

Guru,

Lam,

Akhavan-Sigari

et al. 2024

Brain Sciences

View full text Add to dashboard Cite

The current standard of care for brain tumor management includes maximal safe surgical resection followed by concurrent chemotherapy and radiation therapy. Recent advances in image-guided surgical techniques have enhanced the precision of tumor resections, yet there remains a critical need for innovative technologies to further improve patient outcomes. Techniques such as fluorescence image-guided neurosurgery in combination with stereotactic radiosurgery have improved outcomes for patients with brain tumors. In this article for Brain Science’s Special Issue Recent Advances in Translational Neuro-Oncology, we review the use of image-guided neurosurgery and stereotactic radiosurgery for the treatment of brain tumors. In addition, we summarize the emerging use of theranostic nanoparticles for the delivery of diagnostic and therapeutic technologies to enable the neurosurgeon to perform more precise surgical resections in the operating room, to specifically target the delivery of existing and novel treatments to tumor cells, and to augment the efficacy of stereotactic radiosurgery. These innovative translational tools will allow neurosurgeons, neuro-oncologists, and radiation oncologists to go “beyond the knife” to improve the survival of brain tumor patients.

show abstract

“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology

Guru,

Lam,

Akhavan-Sigari

et al. 2024

Brain Sciences

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Management of large Trigeminal Schwannoma: long-term oncologic and functional outcome from a multicentric retrospective cohort

Cited by 1 publication

References 46 publications

“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology

“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology

Contact Info

Product

Resources

About